Skip to main content
NCBI home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2010 Mar 12;6(1):44–49. doi: 10.1007/s13181-010-0036-3

Dibucaine Toxicosis in a Dog

Andrew S Hanzlicek 1,✉, Deon Van der Merwe 2
PMCID: PMC3550451  PMID: 20224995

Abstract

Introduction

Dibucaine is a potent, long-lasting local anesthetic (LA). Topical dibucaine ointments are marketed directly to consumers in the USA without prescription. Dibucaine ointment is intended to treat discomfort associated with sunburn, eczema, minor rashes, minor scratches, insect bites, and poison ivy and is used alone or in combination with other active ingredients to treat pain associated with hemorrhoids or other anorectal disorders. Oral dibucaine toxicosis has been reported in children and includes gastrointestinal upset and neurologic and cardiovascular dysfunction.

Case Report

An 18-month-old, female, Parson Russell terrier ingested approximately 23 g of 1% dibucaine ointment (approximately 38 mg/kg dibucaine) recommended to the owner for the treatment of hemorrhoids. Onset and resolution of clinical signs were relatively rapid, 5 min and 60 min, respectively. Clinical signs included vomiting, ptyalism, whole-body muscle fasciculations, disorientation, and severe ataxia.

Discussion

Oral dibucaine toxicosis in dogs is similar to oral dibucaine toxicosis in children. Dibucaine ointment poses a real and potentially serious toxicological risk to pets and thus should be stored in a safe location.

Keywords: Canine, Local anesthetic, Neurology, Cardiology, Hemorrhoid

Full Text

The Full Text of this article is available as a PDF (129.5 KB).

References

  • 1.Berde CB. Toxicity of local anesthetics in infants and children. J Pediatr. 1993;122:S14–S20. doi: 10.1016/s0022-3476(11)80004-1. [DOI] [PubMed] [Google Scholar]
  • 2.Strichartz GR, Berde CB. Local anesthetics. In: Miller RD, editor. Miller’s anesthesia. 6. Philadelphia: Elsevier; 2005. pp. 573–603. [Google Scholar]
  • 3.Heavner JE. Local anesthetics. Curr Opin Anaesthesiol. 2007;20:336–342. doi: 10.1097/ACO.0b013e3281c10a08. [DOI] [PubMed] [Google Scholar]
  • 4.Butterworth J, Brownlow RC, Leith JP, Prielipp RC, Cole LR. Bupivicaine inhibits cyclic 3′, 5′ –adenosine monophosphate production. Anesthesiology. 1993;79:88–95. doi: 10.1097/00000542-199307000-00014. [DOI] [PubMed] [Google Scholar]
  • 5.Butterworth J, James RL, Grimes J. Structure-affinity relationships and stereospecificity of several homologous series of local anesthetics for the β2-adrenergic receptor. Anesth Analg. 1997;85:336–342. doi: 10.1097/00000539-199708000-00017. [DOI] [PubMed] [Google Scholar]
  • 6.Zapata-Sudo G, Trachez MM, Sudo RT, Nelson TE. Is comparative cardiotoxicity of S(-) and R(+) bupivicaine related to enantiomer-selective inhibition of L-type Ca2+ channels? Anesth Analg. 2001;92:496–501. doi: 10.1097/00000539-200102000-00040. [DOI] [PubMed] [Google Scholar]
  • 7.Eledjam JJ, de La Coussaye J, Brugada J, Bassoul B, Gagnol JP, Fabregat JR, et al. In vitro study on mechanisms of bupivicaine-induced depression of myocardial contractility Anesth Analg 198969732–735.10.1213/00000539-198912000-00007 [PubMed] [Google Scholar]
  • 8.de Jong R. Local anesthetics. St. Louis: Mosby; 1994. pp. 173–206. [Google Scholar]
  • 9.US Food and Drug Administration [webpage on internet]. Dibucaine drug details [updated daily]. Available from: http://www.accessdata.fda.gov.
  • 10.Golembiewski J. Local anesthetics. J Perianesth Nurs. 2007;22:285–288. doi: 10.1016/j.jopan.2007.05.009. [DOI] [PubMed] [Google Scholar]
  • 11.Igarashi K, Kasuya F, Fukui M. Metabolism of dibucaine. II. Disposition and metabolism of dibucaine in rats. J Pharmcobio-Dyn. 1989;12:523–529. doi: 10.1248/bpb1978.12.523. [DOI] [PubMed] [Google Scholar]
  • 12.Igarashi K, Kasuya F, Fukui M. Metabolism of dibucaine: isolation and identification of urinary basic metabolites in the rat, rabbit and man. J Pharmacobio-Dyn. 1983;6:538–550. doi: 10.1248/bpb1978.6.538. [DOI] [PubMed] [Google Scholar]
  • 13.MSDS Dibucaine. [webpage on internet]. [updated October 9, 2005] Available from: http://sciencelab.com
  • 14.Dayan PS, Litovitz TL, Crouch BI, Scalzo AJ, Klein BL. Fatal accidental dibucaine poisoning in children. Ann Emerg Med. 1996;28:442–445. doi: 10.1016/s0196-0644(96)70013-6. [DOI] [PubMed] [Google Scholar]
  • 15.Becker DE, Reed KL. Essentials of local anesthetic pharmacology. Anesth Prog. 2006;53:98–109. doi: 10.2344/0003-3006(2006)53[98:EOLAP]2.0.CO;2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.de Jong RH, Ronfeld RA, DeRosa RA. Cardiovascular effects of convulsant and supraconvulsant doses of amide local anesthetics. Anesth Analg. 1982;61:3–9. [PubMed] [Google Scholar]
  • 17.MSDS, acetone sodium bisulphate, anhydrous lanolin, and white petroleum [webpage on internet]. Available from: www.msds.com
  • 18.Scott DB. Toxic effects of local anaesthetic agents on the central nervous system. Br J Anaesth. 1986;58:732–735. doi: 10.1093/bja/58.7.732. [DOI] [PubMed] [Google Scholar]
  • 19.Tanaka K, Yamasaki M. Blocking of cortical inhibitory synapses by intravenous lidocaine. Nature. 1966;209:207–208. doi: 10.1038/209207a0. [DOI] [PubMed] [Google Scholar]
  • 20.Liu P, Feldman HS, Covino BM, Giasi R, Covino BG. Acute cardiovascular toxicity of intravenous amide local anesthetics in anesthetized ventilated dogs. Anesth Analg. 1982;61:317–322. [PubMed] [Google Scholar]
  • 21.Liu PL, Feldman HS, Giasi R, Patterson MK, Covino BG.Comparative CNS toxicity of lidocaine, etidocaine, bupivicaine, and tetracaine in awake dogs following rapid intravenous administration Anesth Analg 198362375–379.10.1213/00000539-198304000-00001 [PubMed] [Google Scholar]
  • 22.Altman RS, Smith-Coggins R, Ampel LL. Local anesthetics. Ann Emerg Med. 1985;14:1209–1217. doi: 10.1016/s0196-0644(85)81031-3. [DOI] [PubMed] [Google Scholar]
  • 23.Moller RA, Covino BG. Cardiac electrophysiologic effects of articaine compared with bupivicaine and lidocaine. Anesth Analg. 1993;76:1266–1273. doi: 10.1213/00000539-199306000-00014. [DOI] [PubMed] [Google Scholar]
  • 24.Reiz S, Nath S. Cardiotoxicity of local anesthetic agents. Br J Anaesth. 1986;58:736–746. doi: 10.1093/bja/58.7.736. [DOI] [PubMed] [Google Scholar]
  • 25.Jackson T, McLure HA. Pharmacology of local anesthetics. Opthalmol Clin N Am. 2006;19:155–161. doi: 10.1016/j.ohc.2006.02.006. [DOI] [PubMed] [Google Scholar]
  • 26.The Association of Anesthetists of Great Britain & Ireland [webpage on internet]. Guidelines for the management of severe local anesthetic toxicity [Updated 2007]. Available from: http://www.aagbi.org
  • 27.Kasten GW, Martin ST. Successful cardiovascular resuscitation after massive intravenous bupivicaine over dosage in anesthetized dogs. Anesth Analg. 1985;64:491–497. [PubMed] [Google Scholar]
  • 28.Mama KR, Steffey EP. Local anesthetics. In: Adams HR, editor. Veterinary pharmacology and therapeutics. 8. Ames: Iowa State University Press; 2001. pp. 343–359. [Google Scholar]
  • 29.Mamiya K, Tomoda MK, Edashige K, Ueda W, Manabe M. Local anesthetics enhance nitric oxide production by human peripheral neutrophils. Physiol Chem Phys Med. 1995;27:111–119. [PubMed] [Google Scholar]
  • 30.MSDS #05A Dibucaine Ointment USP 1% [webpage on internet]. [updated September 1, 2005]. Available from: http://www.msdsonline.com.
  • 31.Englesson S. The influence of acid-base changes on central nervous system toxicity of local anaesthetic agents I. Acta Anaesthesiol Scand. 1974;18:79–87. doi: 10.1111/j.1399-6576.1974.tb00846.x. [DOI] [PubMed] [Google Scholar]
  • 32.Englesson S, Grevsten S. The influence of acid-base changes on central nervous system toxicity of local anesthetic agents II. Acta Anaesthesiol Scand. 1974;18:88–103. doi: 10.1111/j.1399-6576.1974.tb00847.x. [DOI] [PubMed] [Google Scholar]
  • 33.Englesson S. Intravenous toxicity-subjective symptoms and acid-base influences on the toxicity of local anaesthetic agents. Acta Anaesthesiol Scand. 1966;25:28–33. [PubMed] [Google Scholar]
  • 34.Rosen MA, Thigpen JW, Shnider SM, Foutz SE, Levinson G, Koike M.Bupivicaine-induced cardiotoxicity in hypoxic and acidotic sheep Anesth Analg 1985641089–96.10.1213/00000539-198511000-00010 [PubMed] [Google Scholar]
  • 35.Moore DC, Crawford RD, Scurlock JE. Severe hypoxia and acidosis following local anesthetic-induced convulsions. Anesthesiology. 1980;53:259–260. doi: 10.1097/00000542-198009000-00020. [DOI] [PubMed] [Google Scholar]
  • 36.Feldman HS, Arthur GR, Pitkanen M, Hurley R, Doucette AM, Covino BG.Treatment of acute systemic toxicity after the rapid intravenous injection of ropivicaine and bupivicaine in the conscious dog Anesth Analg 199173373–384.10.1213/00000539-199110000-00001 [PubMed] [Google Scholar]
  • 37.Cox B, Durieux ME, Marcus MAE. Toxicity of local anesthetics. Best Pract Res Clin Anaesthesiol. 2003;17:111–136. doi: 10.1053/bean.2003.0275. [DOI] [PubMed] [Google Scholar]
  • 38.Saitoh K, Hirabayashi Y, Shimizu R, Fukuda H. Amrinone is superior to epinephrine in reversing bupivicaine-induced cardiovascular depression in sevoflurane-anesthetized dogs. Anesthesiology. 1995;83:127–133. doi: 10.1097/00000542-199507000-00016. [DOI] [PubMed] [Google Scholar]
  • 39.Lindgren L, Randell T, Suzuki N, Kytta J, Yli-Hankala A, Rosenberg PH. The effect of amrinone on recovery from severe bupivicaine intoxication in pigs. Anesthesiology. 1992;77:309–315. doi: 10.1097/00000542-199208000-00014. [DOI] [PubMed] [Google Scholar]
  • 40.Soltesz EG, van Pelt F, Byrne JG. Emergent cardiopulmonary bypass for bupivicaine cardiotoxicity. J Cardiothorac Anesth. 2003;17:357–358. doi: 10.1016/s1053-0770(03)00062-4. [DOI] [PubMed] [Google Scholar]
  • 41.Cho HS, Lee JJ, Chung IS, Shin BS, Kim JA, Lee KH. Insulin reverses bupivicaine-induced cardiac depression in dogs. Anesth Analg. 2000;91:1096–1102. doi: 10.1097/00000539-200011000-00010. [DOI] [PubMed] [Google Scholar]
  • 42.Corman SL, Skledar SJ. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother. 2007;41:1873–1877. doi: 10.1345/aph.1K244. [DOI] [PubMed] [Google Scholar]
  • 43.Warren JA, Thoma RB, Georgescu A, Shah SJ. Intravenous lipid infusion in the successful resuscitation of local anesthetic-induced cardiovascular collapse after supraclavicular brachial plexus block. Anesth Analg. 2008;106:1578–1580. doi: 10.1213/01.ane.0000281434.80883.88. [DOI] [PubMed] [Google Scholar]
  • 44.Litz RJ, Roessel T, Heller AR, Stehr SN. Reversal of central nervous system and cardiac toxicity after local anesthetic intoxication by lipid emulsion injection. Anesth Analg. 2008;106:1575–1577. doi: 10.1213/ane.0b013e3181683dd7. [DOI] [PubMed] [Google Scholar]
  • 45.Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescues dogs from bupivicaine-induced cardiac toxicity. Reg Anesth Pain Med. 2003;28:198–202. doi: 10.1053/rapm.2003.50041. [DOI] [PubMed] [Google Scholar]
  • 46.Weinberg G, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivicaine-induced asystole in rats. Anesthesiology. 1998;88:1071–1075. doi: 10.1097/00000542-199804000-00028. [DOI] [PubMed] [Google Scholar]
  • 47.Picard J. Lipid emulsion to treat overdose of local anaesthetic: the gift of glob. Anaesthesia. 2006;61:107–109. doi: 10.1111/j.1365-2044.2005.04494.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES